China Resources Pharmaceutical Group Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: HK0000311099
HKD
6.27
0.12 (1.95%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Sino Biopharmaceutical Ltd.
WuXi AppTec Co., Ltd.
China Medical System Holdings Ltd.
Sinopharm Group Co., Ltd.
China Resources Pharmaceutical Group Ltd.
Hygeia Healthcare Holdings Co., Ltd.
Hansoh Pharmaceutical Group Co., Ltd.
Innovent Biologics, Inc.
Akeso, Inc.
HUTCHMED (China) Ltd.
BeiGene Ltd.

Why is China Resources Pharmaceutical Group Ltd. ?

1
High Debt Company with a Debt to Equity ratio (avg) at times
  • Poor long term growth as Operating profit has grown by an annual rate 9.87% of over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) at times
2
Poor long term growth as Operating profit has grown by an annual rate 9.87% of over the last 5 years
3
Flat results in Jun 25
  • DEBT-EQUITY RATIO (HY) Highest at 124.92 %
4
With ROE of 19.66%, it has a Very Expensive valuation with a 0.60 Price to Book Value
  • Over the past year, while the stock has generated a return of 20.58%, its profits have risen by 15% ; the PEG ratio of the company is 0.2
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is China Resources Pharmaceutical Group Ltd. for you?

Low Risk, Medium Return

Absolute
Risk Adjusted
Volatility
China Resources Pharmaceutical Group Ltd.
20.58%
0.22
27.48%
Hang Seng Hong Kong
8.25%
0.41
19.93%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
7.98%
EBIT Growth (5y)
9.87%
EBIT to Interest (avg)
3.87
Debt to EBITDA (avg)
2.67
Net Debt to Equity (avg)
1.09
Sales to Capital Employed (avg)
1.87
Tax Ratio
23.92%
Dividend Payout Ratio
25.38%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
12.46%
ROE (avg)
16.20%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
3
Industry P/E
Price to Book Value
0.60
EV to EBIT
6.93
EV to EBITDA
5.37
EV to Capital Employed
0.81
EV to Sales
0.31
PEG Ratio
0.20
Dividend Yield
NA
ROCE (Latest)
11.64%
ROE (Latest)
19.66%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Bullish
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

5What is working for the Company
INTEREST COVERAGE RATIO(Q)

Highest at 857.28

DIVIDEND PAYOUT RATIO(Y)

Highest at 22.21%

RAW MATERIAL COST(Y)

Fallen by -1.46% (YoY

NET SALES(Q)

Highest at HKD 141,644.87 MM

-1What is not working for the Company
DEBT-EQUITY RATIO (HY)

Highest at 124.92 %

Here's what is working for China Resources Pharmaceutical Group Ltd.

Interest Coverage Ratio
Highest at 857.28
in the last five periods
MOJO Watch
The company's ability to manage interest payments is improving

Operating Profit to Interest

Net Sales
Highest at HKD 141,644.87 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (HKD MM)

Dividend Payout Ratio
Highest at 22.21%
in the last five years
MOJO Watch
Company is distributing higher proportion of profits generated as dividend

DPR (%)

Raw Material Cost
Fallen by -1.46% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Depreciation
Highest at HKD 2,027.52 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (HKD MM)

Depreciation
At HKD 2,027.52 MM has Grown at 8.12%
period on period (QoQ)
MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales

Depreciation (HKD MM)

Here's what is not working for China Resources Pharmaceutical Group Ltd.

Debt-Equity Ratio
Highest at 124.92 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio